Scott Eblen to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Scott Eblen has written about Xenograft Model Antitumor Assays.
Connection Strength
0.102
-
EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Carcinogenesis. 2014 May; 35(5):1100-9.
Score: 0.102
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.